Cargando…
TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus
Hydrocephalus is a serious condition that impacts patients of all ages. The standards of care are surgical options to divert, or inhibit production of, cerebrospinal fluid; to date, there are no effective pharmaceutical treatments, to our knowledge. The causes vary widely, but one commonality of thi...
Autores principales: | Hochstetler, Alexandra E., Smith, Hillary M., Preston, Daniel C., Reed, Makenna M., Territo, Paul R., Shim, Joon W., Fulkerson, Daniel, Blazer-Yost, Bonnie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526552/ https://www.ncbi.nlm.nih.gov/pubmed/32938829 http://dx.doi.org/10.1172/jci.insight.137646 |
Ejemplares similares
-
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models
por: Hochstetler, Alexandra, et al.
Publicado: (2023) -
Hydrocephalus: historical analysis and considerations for treatment
por: Hochstetler, Alexandra, et al.
Publicado: (2022) -
Hydrocephalus in a rat model of Meckel Gruber syndrome with a TMEM67 mutation
por: Shim, Joon W., et al.
Publicado: (2019) -
Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus
por: Blazer-Yost, Bonnie L.
Publicado: (2023) -
Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus
por: Shim, Joon W., et al.
Publicado: (2016)